The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome

Paediatric Anaesthesia

Volumn 17, Issue 11, 2007, Pages 1071-1077

  Kageyama, Kyoko ^a   Hashimoto, Soshi ^a   Nakajima, Yasufumi ^a   Shime, Nobuaki ^a   Hashimoto, Satoru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Congenital heart disease; Down syndrome; Pediatric patient; Plasma endothelin 1; Pulmonary hypertension

Indexed keywords

ENDOTHELIN 1;

ANESTHESIA MECHANISM; ARTICLE; BREATHING RATE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HEART RATE; HUMAN; INFANT; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

CARDIOPULMONARY BYPASS; DOWN SYNDROME; ENDOTHELIN-1; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; LINEAR MODELS; LUNG DISEASES, OBSTRUCTIVE; MALE; MONITORING, INTRAOPERATIVE; TIME FACTORS;

EID: 34748818710     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02296.x     Document Type: Article

References (14)

1. Chi TL, Krovetz J. The pulmonary vascular bed in children with Down syndrome. J Pediatr 1975 86 : 533 538.
2. Soudon P, Stijns M, Tremouroux-Wattiez M et al. Precocity of pulmonary vascular obstruction of Down's syndrome. Eur J Cardiol 1975 2 : 473 476.
3. Yamaki S, Horiuchi T, Sekino Y. Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol 1983 51 : 1502 1506.
4. Yoshibayashi M, Nishioka K, Nakao K et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991 84 : 2280 2285.
5. Beghetti M, Black SM, Fineman JR. Endothelin-1 in congenital heart disease. Pediatr Res 2005 57 : 16R 20R.
6. Medicus L, Thompson L. Preventing pulmonary hypertensive crisis in the pediatric patient after cardiac surgery. Am J Crit Care 1995 4 : 49 53.
7. Brunner F, du Toit EF, Opie LH. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 1992 24 : 1291 1305.
8. Hynynen M, Saijonmaa O, Tikkanen I et al. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass: a preliminary observation. J Thorac Cardiovasc Surg 1992 103 : 1024 1025.
9. Hiramatsu T, Imai Y, Takanashi Y et al. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects. Ann Thorac Surg 1997 63 : 648 652.
10. Spicer RL. Cardiovascular disease in Down syndrome. Pediatr Clin North Am 1984 31 : 1331 1343.
11. Yamaki S, Horiuchi T, Takahashi T. Pulmonary changes in congenital heart disease with Down's syndrome: their significance as a cause of postoperative respiratory failure. Thorax 1985 40 : 380 386.
12. Hasegawa N, Oshima M, Kawakami H et al. Changes in pulmonary tissue of patients with congenital heart disease and Down syndrome: a morphological and histochemical study. Acta Paediatr Jpn 1990 32 : 60 66.
13. Bond BR, Dorman BH, Clair MJ et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 2001 122 : 358 364.
14. Bando K, Vijayaraghavan P, Turrentine MW et al. Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease. Circulation 1997 96 : 346 351.